We have developed a sophisticated therapeutic antibody R&D system, which consists of a technology platform for antibody discovery and optimization based on the dynamic integration of computer aided design (CAD) and mammalian cell display as well as platforms for in vitro activity evaluation, in vivo efficacy evaluation and druggability analysis. We have also created unique systems in bispecific antibodies and other fields and deployed abundant innovative antibody drug pipelines in the tumor field.


We have built the high efficiency antibody expression system, antibody-based fucose removal technology system, druggability evaluation system of drug candidates and a full chain technology system from construction of cell lines, through cell culture, purification, preparation process development and amplification, to antibody quality control and antibody scale production.

Copyright Rm. 301, F3, Building C, Block 2, No. 688, Bin'an Road, Changhe Zhejiang ICP Filing No. 18039044